Science & Enterprise subscription

Follow us on Twitter

  • https://t.co/j6Bc09NhlE
    about 24 hours ago
  • A new analysis from technology intelligence company GlobaData shows the top 2 enterprises attracting venture financ… https://t.co/Qfo4gwNJqW
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Germany Beats U.K. in Top Venture Funds https://t.co/IdlaDYgl9U #Science #Business
    about 2 days ago
  • New contributed post on Science and Enterprise: https://t.co/sGLg6tmIwx Protecting A Modern Agricultural Business
    about 2 days ago
  • An engineering-psychology team is developing a system connecting virtual reality with brain signals in real time t… https://t.co/mF081BrzQX
    about 3 days ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Crispr Diagnostics Company Launches with $35M Funding

Sherlock paper test strips

Sherlock Biosciences Inc., a new enterprise offering medical diagnostics based on the genome-editing technology Crispr, is starting up with $35 million in seed financing. . . . → Read More: Crispr Diagnostics Company Launches with $35M Funding

Spin-Off Producing Commercial-Grade Graphene

Graphene illustration

A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics. . . . → Read More: Spin-Off Producing Commercial-Grade Graphene

Start-Up Creating Touch Sensing for Visual Images

Ting Zhang and Shruthi Suresh

A start-up company spun off from Purdue University is developing a system that translates visual images to touch-sensing signals for people with limited visual abilities. . . . → Read More: Start-Up Creating Touch Sensing for Visual Images

Start-Up Raises $10.5M for Precision Immunotherapies

Business newspaper

A new biotechnology enterprise developing personalized treatments that harness the immune system to treat cancer is raising $10.5 million in its first venture funding round. . . . → Read More: Start-Up Raises $10.5M for Precision Immunotherapies

MIT Spins-Off 32 Start-Ups in 2018

Lesley Millar-Nicholson

Research done at Massachusetts Institute of Technology in 2018 led to creation of 32 new start-up enterprises as well as hundreds of licenses and patents. . . . → Read More: MIT Spins-Off 32 Start-Ups in 2018

UC-Berkeley to Get New Crispr Patent

U.S. Patent and Trademark Office

University of California in Berkeley will soon receive a new patent for its development of the genome editing process known as Crispr, the latest round in a years-long dispute. . . . → Read More: UC-Berkeley to Get New Crispr Patent

Company to Stop Cancer Spread, Relapse Raises $60.8M

Cancer magnified

A new company formed to commercialize research that aims to prevent cancer from spreading or recurring is raising $60.75 million in its first venture financing. . . . → Read More: Company to Stop Cancer Spread, Relapse Raises $60.8M

Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal

Neurons illustration

Eli Lilly and Co. is licensing a a treatment candidate for Alzheimer’s disease from biopharmaceutical company AC Immune that aims to block accumulation of tau proteins in the brain. . . . → Read More: Lilly, Biopharm Partner on Alzheimer’s Treatment in $2B Deal

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Janssen Licensing Cancer Antibodies in $1.8B Deal

Llama

An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas. . . . → Read More: Janssen Licensing Cancer Antibodies in $1.8B Deal